205 related articles for article (PubMed ID: 21450976)
1. In Vitro and In Vivo studies of monoclonal antibodies with prominent bactericidal activity against Burkholderia pseudomallei and Burkholderia mallei.
Zhang S; Feng SH; Li B; Kim HY; Rodriguez J; Tsai S; Lo SC
Clin Vaccine Immunol; 2011 May; 18(5):825-34. PubMed ID: 21450976
[TBL] [Abstract][Full Text] [Related]
2. Relationship between antigenicity and pathogenicity for Burkholderia pseudomallei and Burkholderia mallei revealed by a large panel of mouse MAbs.
Zou N; Tsai S; Feng SH; Newsome T; Kim HY; Li B; Zhang S; Lo SC
Hybridoma (Larchmt); 2008 Aug; 27(4):231-40. PubMed ID: 18707541
[TBL] [Abstract][Full Text] [Related]
3. Construction and molecular characterization of mouse single-chain variable fragment antibodies against Burkholderia mallei and Burkholderia pseudomallei.
Kim HS; Tsai S; Zou N; Lo SC; Wear DJ; Izadjoo MJ
J Immunol Methods; 2011 Feb; 365(1-2):101-9. PubMed ID: 21172353
[TBL] [Abstract][Full Text] [Related]
4. Antibodies against
Zimmerman SM; Dyke JS; Jelesijevic TP; Michel F; Lafontaine ER; Hogan RJ
Infect Immun; 2017 Aug; 85(8):. PubMed ID: 28507073
[No Abstract] [Full Text] [Related]
5. Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders.
Sarkar-Tyson M; Smither SJ; Harding SV; Atkins TP; Titball RW
Vaccine; 2009 Jul; 27(33):4447-51. PubMed ID: 19490962
[TBL] [Abstract][Full Text] [Related]
6. Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders.
Moustafa DA; Scarff JM; Garcia PP; Cassidy SK; DiGiandomenico A; Waag DM; Inzana TJ; Goldberg JB
PLoS One; 2015; 10(7):e0132032. PubMed ID: 26148026
[TBL] [Abstract][Full Text] [Related]
7. Production and characterization of chimeric monoclonal antibodies against Burkholderia pseudomallei and B. mallei using the DHFR expression system.
Kim HY; Tsai S; Lo SC; Wear DJ; Izadjoo MJ
PLoS One; 2011 May; 6(5):e19867. PubMed ID: 21573027
[TBL] [Abstract][Full Text] [Related]
8. Human single-chain Fv antibodies against Burkholderia mallei and Burkholderia pseudomallei.
Zou N; Newsome T; Li B; Tsai S; Lo SC
Exp Biol Med (Maywood); 2007 Apr; 232(4):550-6. PubMed ID: 17392491
[TBL] [Abstract][Full Text] [Related]
9. Use of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in mice.
Lafontaine ER; Zimmerman SM; Shaffer TL; Michel F; Gao X; Hogan RJ
PLoS One; 2013; 8(10):e76804. PubMed ID: 24098563
[TBL] [Abstract][Full Text] [Related]
10. Development of mouse hybridomas for production of monoclonal antibodies specific to Burkholderia mallei and Burkholderia pseudomallei.
Feng SH; Tsai S; Rodriguez J; Newsome T; Emanuel P; Lo SC
Hybridoma (Larchmt); 2006 Aug; 25(4):193-201. PubMed ID: 16934015
[TBL] [Abstract][Full Text] [Related]
11. Developing Peptide Mimotopes of Capsular Polysaccharides and Lipopolysaccharides Protective Antigens of Pathogenic Burkholderia Bacteria.
Guo P; Zhang J; Tsai S; Li B; Lo SC
Monoclon Antib Immunodiagn Immunother; 2016 Jun; 35(3):125-34. PubMed ID: 27328059
[TBL] [Abstract][Full Text] [Related]
12. Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders.
Burtnick MN; Heiss C; Roberts RA; Schweizer HP; Azadi P; Brett PJ
Front Cell Infect Microbiol; 2012; 2():108. PubMed ID: 22912938
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies passively protect BALB/c mice against Burkholderia mallei aerosol challenge.
Treviño SR; Permenter AR; England MJ; Parthasarathy N; Gibbs PH; Waag DM; Chanh TC
Infect Immun; 2006 Mar; 74(3):1958-61. PubMed ID: 16495574
[TBL] [Abstract][Full Text] [Related]
14. Burkholderia Hep_Hag autotransporter (BuHA) proteins elicit a strong antibody response during experimental glanders but not human melioidosis.
Tiyawisutsri R; Holden MT; Tumapa S; Rengpipat S; Clarke SR; Foster SJ; Nierman WC; Day NP; Peacock SJ
BMC Microbiol; 2007 Mar; 7():19. PubMed ID: 17362501
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a latex agglutination assay for the identification of Burkholderia pseudomallei and Burkholderia mallei.
Duval BD; Elrod MG; Gee JE; Chantratita N; Tandhavanant S; Limmathurotsakul D; Hoffmaster AR
Am J Trop Med Hyg; 2014 Jun; 90(6):1043-6. PubMed ID: 24710616
[TBL] [Abstract][Full Text] [Related]
16. Antigenic relatedness between Burkholderia pseudomallei and Burkholderia mallei.
Anuntagool N; Sirisinha S
Microbiol Immunol; 2002; 46(3):143-50. PubMed ID: 12008922
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Burkholderia mallei ΔtonB Δhcp1 (CLH001) as a live attenuated vaccine in murine models of glanders and melioidosis.
Khakhum N; Bharaj P; Myers JN; Tapia D; Walker DH; Endsley JJ; Torres AG
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007578. PubMed ID: 31306423
[TBL] [Abstract][Full Text] [Related]
18. Polysaccharide microarray technology for the detection of Burkholderia pseudomallei and Burkholderia mallei antibodies.
Parthasarathy N; DeShazer D; England M; Waag DM
Diagn Microbiol Infect Dis; 2006 Nov; 56(3):329-32. PubMed ID: 16765554
[TBL] [Abstract][Full Text] [Related]
19. Development of Burkholderia mallei and pseudomallei vaccines.
Silva EB; Dow SW
Front Cell Infect Microbiol; 2013; 3():10. PubMed ID: 23508691
[TBL] [Abstract][Full Text] [Related]
20. Distinct human antibody response to the biological warfare agent Burkholderia mallei.
Varga JJ; Vigil A; DeShazer D; Waag DM; Felgner P; Goldberg JB
Virulence; 2012 Oct; 3(6):510-4. PubMed ID: 23076276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
